LUPIN LIMITED Valuation
LUPIN · Healthcare · Current price ₹2,443.2
Is LUPIN LIMITED undervalued?
DocStoX estimates the fair value of LUPIN LIMITED at ₹1,878 per share, versus the current market price of ₹2,443. That puts the stock about -23.1% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹998), Relative P/E (₹4,050), Graham floor (₹1,135). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹998 (bear) to ₹1,878 (base) to ₹4,050 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
LUPIN LIMITED trades at a P/E of 20.9x and a P/B of 4.9x, with a dividend yield of 0.7%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on LUPIN LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.